M

M3 Wake Research | Tucson Neuroscience Research

Research site

(Unclaimed)

Location

6567 East Carondelet, Suite 475, Tucson, Arizona, United States of America

Site insights

Top conditions

Top treatments

ABP-671

Semaglutide

Rimegepant

Pimavanserin

Zavegepant

Semagludtide

Glucose

JNJ-40411813

Azeliragon

Levetiracetam

Parent organization

This site is a part of M3 Wake Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 24 total trials

A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants will either get sem...

Active, not recruiting

Early Alzheimer´s Disease

Drug: Placebo (semaglutide)

Drug: Semaglutide

A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease.Participants will either get sem...

Active, not recruiting

Early Alzheimer's Disease

Drug: Placebo (semaglutide)

Drug: Semagludtide

Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease (TargetTau-1)

The purpose of this study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants...

Active, not recruiting

Alzheimer Disease, Early Onset

Other: Placebo

Drug: BMS-986446